Tom Wilemon

July 15, 2021

Ciombor chosen for NCI clinical investigator team leadership award

Kristen Ciombor, MD, MSCI, is one of 10 physicians nationwide selected by the National Cancer Institute (NCI) for the 2021 Cancer Clinical Investigator Team Leadership Award.

By Tom Wilemon
July 15, 2021

Susan G. Komen funds VICC breast cancer initiatives

Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.

By Tom Wilemon
July 14, 2021

Davis promoted to Vice President for VUMC Cancer Care Network and Strategy

Nancy Davis, MD, has been promoted to Vice President for Cancer Care Network and Strategy at Vanderbilt University Medical Center, a new position responsible for developing provider relationships with other health care systems and expanding access to oncology care throughout Tennessee and other states.

By Tom Wilemon
July 1, 2021

Preclinical study supports rigosertib as booster to immunotherapy treatment for melanoma

A team of Vanderbilt researchers have shown in a preclinical study that the investigational drug rigosertib could be a potential booster treatment to elicit response to immunotherapies among melanoma patients.

By Tom Wilemon
June 24, 2021

Tuya Pal named Komen Scholar

Susan G. Komen announced on June 23 that Tuya Pal, MD, associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Cancer Research, has been named a Komen Scholar.

By Tom Wilemon
June 23, 2021

Study shows benefit of scheduling lung screens with mammograms

Women who are longtime smokers could potentially save their lives by undergoing lung screens on the same day they schedule mammograms, according to a study by Vanderbilt researchers published in the Journal of Medical Screening.

By Tom Wilemon
June 9, 2021

National Black Family Cancer Awareness Week is call to action

National Black Family Cancer Awareness Week, June 17-23, aims to spur conversations followed by actions to make advancements in care more equitable.
By Tom Wilemon
May 26, 2021

Vanderbilt researchers present new data on clinical trials at ASCO 2021

Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.
By Tom Wilemon
May 24, 2021

Analysis reveals macrophages associated with kidney cancer recurrence

A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.
By Tom Wilemon
May 20, 2021

William and Frances Blot deed home to VUMC to benefit cancer patients

Their condominium in The Westbury was at the heart of all that William and Frances Blot loved about Nashville — its proximity to Vanderbilt where he worked for two decades, its sidewalk that led to the greenspaces where they would watch the seasons change, and its residents who became more like friends than neighbors.
By Tom Wilemon
May 13, 2021

People at high genetic risk for colorectal cancer benefit more from lifestyle changes

People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
By Tom Wilemon
May 12, 2021

AACR second session to feature Vanderbilt researchers

The second session of the American Association for Cancer Research (AACR) Annual meeting, May 17-21, features several researchers from Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
1 … 9 10 11 12 13 … 35